NervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291.

Press/Media: Press / Media

PeriodOct 19 2020

Media coverage

1

Media coverage

  • TitleNervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291.
    Media name/outletFinancial News Releases
    CountryCanada
    Date10/19/20
    PersonsMichael A Davis